Glucagon - Fresenius KabiAlternative Names: Glucagon for Injection - Fresenius Kabi
Latest Information Update: 18 Aug 2015
At a glance
- Originator Fresenius Kabi
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Gastrointestinal motility disorders
Most Recent Events
- 27 Jul 2015 Launched for Gastrointestinal motility disorders in USA (IM, IV)